首页 > 市场调查报告书 > 医疗设备

心血管设备

市场调查报告书

商品编码

1498689

全球心臟瓣膜刀市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Cardiac Valvulotome Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年06月01日 | 出版商:

Value Market Research | 英文 177 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球心臟瓣膜刀市场需求预计将从 2023 年的 1.3417 亿美元达到 2032 年的近 2.0831 亿美元，2024-2032 年研究期间复合年增长率为 5.01%。

心臟瓣膜切开器是一种用于心臟手术中进行瓣膜切开术的手术器械，其中涉及手术切口或打开心臟瓣膜。该装置旨在透过扩大或修復受影响的瓣膜来促进各种心臟瓣膜疾病的治疗，包括狭窄（变窄）或逆流（洩漏）。在手术过程中，瓣膜刀透过一个小切口小心地插入心室，使外科医生能够进入受影响的瓣膜并执行必要的纠正措施。心臟瓣膜切开术通常用于缓解与心臟瓣膜疾病相关的症状并改善整体心臟功能，从而提高患者的生活品质。

市场动态

推动心臟瓣膜刀市场的因素主要围绕在全球心血管疾病盛行率的不断上升，特别是在老年人口中。随着心臟病变得越来越普遍，对解决这些问题的先进医疗设备和程序的需求不断增加。此外，心臟手术技术和设备的技术进步对市场成长做出了重大贡献，提高了涉及心臟瓣膜刀的手术的有效性和安全性。此外，患者和医疗保健提供者对微创手术选择的认识不断提高，进一步推动了对心臟瓣膜刀的需求，因为它提供了比传统心臟直视手术侵入性更小的方法。此外，医疗器材公司和医疗机构之间的合作和伙伴关係推动了市场创新，从而开发出更有效率、更精确的设备。然而，日益严格的医疗器材监管审查和严格的审批流程可能会对未来几年的市场成长构成挑战。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球心臟瓣膜刀市场的各个细分市场进行了包容性评估。心臟瓣膜刀产业的成长和趋势为本研究提供了整体方法。

市场区隔

心臟瓣膜刀市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按类型

可扩张心臟瓣膜刀
有线心臟瓣膜切开器

按程式类型

瓣膜切开术
二尖瓣连合切开术
其他（三尖瓣狭窄等）

按最终用户

医院和诊所
心臟手术中心
门诊手术中心
其他（研究所等）

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲心臟瓣膜刀市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。心臟瓣膜刀市场的主要参与者包括LeMaitre、Invamed、LimFlow Inc.、B. Braun、Teleflex Incorporated、StarFish Medical、Koven Technology Inc.、BD、Symmetry Surgical Inc.、Andramed GmbH、OxSyBio。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：心臟瓣膜刀公司的竞争格局

心臟瓣膜刀市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
LeMaitre

公司简介
公司收入
产品
最近的发展

Invamed

公司简介
公司收入
产品
最近的发展

LimFlow Inc.

公司简介
公司收入
产品
最近的发展

B. Braun

公司简介
公司收入
产品
最近的发展

Teleflex Incorporated

公司简介
公司收入
产品
最近的发展

StarFish Medical

公司简介
公司收入
产品
最近的发展

Koven Technology Inc.

公司简介
公司收入
产品
最近的发展

公司简介
公司收入
产品
最近的发展

Symmetry Surgical Inc.

公司简介
公司收入
产品
最近的发展

Andramed GmbH

公司简介
公司收入
产品
最近的发展

OxSyBio

公司简介
公司收入
产品
最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112114869

The global demand for Cardiac Valvulotome Market is presumed to reach the market size of nearly USD 208.31 Million by 2032 from USD 134.17 Million in 2023 with a CAGR of 5.01% under the study period 2024-2032.

A cardiac valvulotome is a surgical instrument utilized in cardiac procedures to perform valvulotomy, which involves the surgical incision or opening of a heart valve. This device is designed to facilitate the treatment of various heart valve conditions, including stenosis (narrowing) or regurgitation (leakage), by widening or repairing the affected valve. During the procedure, the valvulotome is carefully inserted into the heart's chambers through a small incision, allowing surgeons to access the affected valve and perform the necessary corrective measures. Cardiac valvulotomy procedures are often performed to alleviate symptoms associated with heart valve disorders and improve overall cardiac function, thereby enhancing the patient's quality of life.

MARKET DYNAMICS

Factors driving the cardiac valvulotome market primarily revolve around the increasing prevalence of cardiovascular diseases globally, particularly among the aging population. As cardiac conditions become more prevalent, there's a rising demand for advanced medical devices and procedures to address them. Additionally, technological advancements in cardiac surgery techniques and equipment contribute significantly to the market growth, enhancing the efficacy and safety of procedures involving cardiac valvulotome. Moreover, rising awareness among patients and healthcare providers about minimally invasive surgical options further propels the demand for cardiac valvulotome, as it offers a less invasive approach than traditional open-heart surgeries. Furthermore, collaborations and partnerships between medical device companies and healthcare institutions drive innovation in the market, leading to the development of more efficient and precise devices. However, increasing regulatory scrutiny and stringent approval processes for medical devices may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cardiac Valvulotome. The growth and trends of Cardiac Valvulotome industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cardiac Valvulotome market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Expandable Cardiac Valvulotome
Over the Wire Cardiac Valvulotome

By Procedure Type

Valvulotomy
Mitral Valve Commissurotomy
Others (Tricuspid Valve Stenosis, etc.)

By End-user

Hospitals & Clinics
Cardiac Surgery Centers
Ambulatory Surgical Centers
Others (research Institutes, etc.)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cardiac Valvulotome market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cardiac Valvulotome market include LeMaitre, Invamed, LimFlow Inc., B. Braun, Teleflex Incorporated, StarFish Medical, Koven Technology Inc., BD, Symmetry Surgical Inc., Andramed GmbH, OxSyBio. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CARDIAC VALVULOTOME - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Procedure Type
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CARDIAC VALVULOTOME MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Expandable Cardiac Valvulotome Historic and Forecast Sales By Regions
5.4. Over the Wire Cardiac Valvulotome Historic and Forecast Sales By Regions

6. GLOBAL CARDIAC VALVULOTOME MARKET ANALYSIS BY PROCEDURE TYPE

6.1. Overview By Procedure Type
6.2. Historical and Forecast Data Analysis By Procedure Type
6.3. Valvulotomy Historic and Forecast Sales By Regions
6.4. Mitral Valve Commissurotomy Historic and Forecast Sales By Regions
6.5. Others (Tricuspid Valve Stenosis, etc.) Historic and Forecast Sales By Regions

7. GLOBAL CARDIAC VALVULOTOME MARKET ANALYSIS BY END-USER

7.1. Overview By End-user
7.2. Historical and Forecast Data Analysis By End-user
7.3. Hospitals & Clinics Historic and Forecast Sales By Regions
7.4. Cardiac Surgery Centers Historic and Forecast Sales By Regions
7.5. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
7.6. Others (research Institutes, etc.) Historic and Forecast Sales By Regions

8. GLOBAL CARDIAC VALVULOTOME MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CARDIAC VALVULOTOME COMPANIES

9.1. Cardiac Valvulotome Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF CARDIAC VALVULOTOME INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. LeMaitre
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Invamed
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. LimFlow Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. B. Braun
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Teleflex Incorporated
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. StarFish Medical
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Koven Technology Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. BD
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Symmetry Surgical Inc.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Andramed GmbH
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. OxSyBio
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments